CSIG-23. miR-146a PREDICTS BETTER OVERALL SURVIVAL AND ACTS AS A TEMOZOLOMIDE (TMZ) SENSITIZER THROUGH TARGETING MULTIPLE SIGNALING PATHWAYS IN GLIOBLASTOMA
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.